SHELLY MATHUR
Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism SUGAR LAND, TX NPI 1831344530
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Endocrinology, Diabetes & Metabolism TX Lilly USA, LLC All categories
General Payments — all program years on this page
$8,830.24
- Category: General Payments
- Program years: PY2018–2024
- Record count: 503
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $978.93 across 48 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $978.93 | 48 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Lilly USA, LLC | $189.94 | 8 |
| Amgen Inc. | $140.12 | 7 |
| Novo Nordisk AS | $138.78 | 8 |
| Radius Health, Inc. | $80.73 | 3 |
| ABBVIE INC. | $64.94 | 4 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $42.93 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $42.81 | 2 |
| Xeris Pharmaceuticals, Inc. | $37.17 | 2 |
| Insulet Corporation | $33.16 | 1 |
| Alexion Pharmaceuticals, Inc. | $25.03 | 1 |
| Kyowa Kirin, Inc. | $25.00 | 1 |
| BETA BIONICS, INC. | $24.81 | 1 |
| Corcept Therapeutics | $22.74 | 1 |
| Amneal Pharmaceuticals LLC | $20.64 | 1 |
| Tandem Diabetes Care, Inc. | $19.36 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $16.15 | 1 |
| Currax Pharmaceuticals LLC | $15.62 | 1 |
| Abbott Laboratories | $14.31 | 1 |
| IBSA Pharma Inc. | $14.01 | 1 |
| CeQur Corporation | $10.68 | 1 |
By program year
Records — PY2024 (48)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.